This narrative review explores how gut microbes and their metabolites might influence the aging process. The authors look at short-chain fatty acids, bile acids, and other compounds produced by these microbes. They aim to understand how these biological factors interact with the body over time. However, the review highlights that little direct evidence exists in humans. Most of the current information comes from animal studies rather than tests performed directly on people. The authors note that both gut microbes and the human body change constantly as we age, making it hard to see cause and effect clearly. Because of this, the review states that cause and effect needs further determination through broad, long-term studies. Understanding this system better could eventually help create new biomarkers and treatments to influence aging by targeting the microbiome and its effects on epigenetics. Until more human data is available, readers should be cautious about claiming specific benefits or risks based on this review alone.
Gut microbes and metabolites may influence aging, though human evidence remains limitedGut microbes may influence aging, but human evidence remains limited
AI-generated summary of the cited source, checked by automated accuracy review. How we work
This narrative review explores the potential role of gut microbes and their metabolites, including short-chain fatty acids, bile acids, tryptophan derivatives, and polyamines, in the aging process. The scope of the article focuses on the theoretical connections between the microbiome and epigenetics rather than reporting specific clinical trial data or human outcomes. The authors highlight that little direct evidence exists in humans to support definitive clinical claims at this time.
Most of the current evidence originates from animal studies rather than direct tests in people. Consequently, the review emphasizes that the causal pathways between gut microbes and the body remain unclear as both systems change constantly over time. The authors aim to distinguish direct effects from indirect changes but note that cause and effect needs further determination via broad, long-term studies.
The practice relevance of this work lies in the potential for future applications. Understanding this system better could help create new biomarkers and treatments to influence aging by targeting the microbiome and its effects on epigenetics. However, clinicians should interpret these findings cautiously given the lack of human data and the reliance on preclinical models.